<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2024-2298</article-id><article-id custom-type="edn" pub-id-type="custom">CSWYCZ</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-2298</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Субклинический каротидный атеросклероз: роль неспецифического воспаления, холестериновой, гипертензивной нагрузки и пола у вахтовиков  в Арктике</article-title><trans-title-group xml:lang="en"><trans-title>Subclinical carotid atherosclerosis: role of inflammation, cholesterol, hypertensive load and sex in rotational shift work in the Arctic</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3038-6445</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шуркевич</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Shurkevich</surname><given-names>N. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шуркевич Нина Петровна — доктор медицинских наук, ведущий научный сотрудник отделения артериальной гипертонии и коронарной недостаточности научного отдела клинической кардиологии</p><p>ул. Мельникайте, д.111, Тюмень, 625026</p><p>Тел.: 8 (3452) 20–42–37</p></bio><bio xml:lang="en"><p>Nina P. Shurkevich, MD, PhD, DSc, Leading Scientific Researcher, Arterial Hypertension and Coronary Insufficiency Department of the Scientific Division of Clinical Cardiology</p><p>111 Melnikaite str., Tyumen, 625026</p></bio><email xlink:type="simple">Shurkevich@infarkta.net</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9802-2632</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ветошкин</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Vetoshkin</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ветошкин Александр Семенович — доктор медицинских наук, старший научный сотрудник отделения артериальной гипертонии и коронарной недостаточности научного отдела клинической кардиологии</p><p>Тюмень</p></bio><bio xml:lang="en"><p>Alexander S. Vetoshkin, MD, PhD, DSc, Senior Researcher, Arterial Hypertension and Coronary Insufficiency Department of the scientific division of Clinical Cardiology</p><p>Tyumen</p></bio><email xlink:type="simple">Vetalex@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4371-7522</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Симонян</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Simonyan</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Симонян Ани Арсеновна — врач-кардиолог отделения артериальной гипертонии и коронарной недостаточности научного отдела клинической кардиологии, Тюменский кардиологический научный центр</p><p>Тюмень</p></bio><bio xml:lang="en"><p>Ani A. Simonyan, MD, Сardiologist, Scientific Division of Clinical Cardiology</p><p>Tyumen</p></bio><email xlink:type="simple">Anchoi@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3620-0659</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гапон</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Gapon</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гапон Людмила Ивановна — доктор медицинских наук, профессор, заслуженный деятель науки Российской Федерации, руководитель научного отдела клинической кардиологии, Тюменский кардиологический научный центр</p><p>Тюмень</p></bio><bio xml:lang="en"><p>Lyudmila I. Gapon, MD, PhD, DSc, Professor, Honored Scientist of the Russian Federation, Head, Scientific Division of Clinical Cardiology</p><p>Tyumen</p></bio><email xlink:type="simple">Gapon@infarkta.net</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7200-8111</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карева</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kareva</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Карева Мария Андреевна — врач-кардиолог отделения артериальной гипертонии и коронарной недостаточности научного отдела клинической кардиологии</p><p>Тюмень</p></bio><bio xml:lang="en"><p>Maria A. Kareva, MD, Cardiologist, Scientific Division of Clinical Cardiology</p><p>Tyumen</p></bio><email xlink:type="simple">KarevaMA@infarkta.net</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Тюменский кардиологический научный центр, Томский национальный исследовательский медицинский центр Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>13</day><month>11</month><year>2023</year></pub-date><volume>30</volume><issue>1</issue><fpage>70</fpage><lpage>82</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шуркевич Н.П., Ветошкин А.С., Симонян А.А., Гапон Л.И., Карева М.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Шуркевич Н.П., Ветошкин А.С., Симонян А.А., Гапон Л.И., Карева М.А.</copyright-holder><copyright-holder xml:lang="en">Shurkevich N.P., Vetoshkin A.S., Simonyan A.A., Gapon L.I., Kareva M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/2298">https://htn.almazovcentre.ru/jour/article/view/2298</self-uri><abstract><p>Актуальность. Атеросклероз является основной причиной сердечно-сосудистых заболеваний во всем мире, но сроки развития заболевания различаются у полов, что позволяет предположить, что механизмы, в том числе иммунные, которые усиливают заболевание у мужчин (М) и женщин (Ж), отличаются. Цель исследования — изучить вероятность выявления субклинического каротидного атеросклероза (СКА) в зависимости от пола, наличия артериальной гипертензии (АГ), иммунного воспаления и некоторых метаболических факторов риска у лиц в условиях арктической вахты. Материалы и методы. В заполярном поселке Ямбург (68° 21’ 40” с. ш.) на базе медико-санитарной части ООО «Газпром добыча Ямбург» одномоментно обследовано 99 М и 81 Ж с АГ 1‑й, 2‑й степени и нормотензивных лиц, сопоставимых по возрасту (р = 0,450), северному стажу (р = 0,956), числу лет работы вахтой (р = 0,824), уровню офисного систолического артериального давления (АД) (р = 0,251) и диастолического АД (р = 0,579). Проведено суточное мониторирование АД; ультразвуковое исследование сонных артерий с определением наличия (отсутствия) атеросклеротической бляшки; биохимическое исследование крови с определением липидного спектра, биомаркеров системного воспаления, интерлейкинов, кортизола, половых гормонов и некоторых метаболических факторов риска. Результаты. Проведен анализ в группах М и Ж с наличием СКА (n = 98) и без СКА (n = 82), из них в 1‑й группе — 57 М (58%), 41 Ж (51%), Рχ2 = 0,612; также в группах М и Ж с наличием и без АГ. У М незначимо чаще выявлялся СКА. Получены различия между группами с СКА и без СКА: у Ж с АГ по уровням высокочувствительного С-реактивного белка (вч-СРБ) (р = 0,018), интерлейкина 1β (IL‑1β) (р = 0,045) и IL‑10 (р = 0,017); у М с АГ по концентрации кортизола (р = 0,049), вч-СРБ (р = 0,046), IL‑1β (р = 0,033); у М с нормальным АД — по уровню вч-СРБ (р = 0,052), кортизола (р = 0,036), гомоцистеина (р = 0,042), IL‑6 (р = 0,009); у нормотензивных Ж — по уровню общего холестерина (р = 0,039), холестерина липопротеинов очень низкой плотности (ХС ЛПОНП) (р = 0,026), Аро-В (р = 0,026); фолликулостимулирующего гормона (р = 0,019), тестостерона (р = 0,044). По данным логистической регрессии, наличие АГ увеличивало вероятность выявления СКА у М в 1,2 раза (р = 0,045), ХС ЛПОНП (отношение шансов (ОШ) 1,680; 95% доверительный интервал (ДИ) 1,014–2,811; р = 0,038), IL‑10 (ОШ 0,757; 95% ДИ 0,096–0,958; р = 0,048), вч-СРБ (ОШ 1,346; 95% ДИ 1,047–1,613; р = 0,042) и С-пептида (ОШ 1,151; 95% ДИ 1,035–1,416; р = 0,044); у Ж вероятность визуализации СКА не зависела от наличия АГ, но была ассоциирована с ХС ЛПОНП (ОШ 4,411; 95% ДИ 1,021–7,911; р = 0,002), гомоцистеином (ОШ 1,537; 95% ДИ 1,092–2,163; р = 0,014), Аро-В (ОШ 1,172; 95% ДИ 1,042–1,317; р = 0,008), тестостероном (ОШ 1,008; 95 % ДИ 1,001–1,016; р = 0,031), IL‑10 (ОШ 0,250; 95 % ДИ 0,072–0,872; р = 0,030). Заключение. В условиях арктической вахты СКА чаще выявляется у М. Наличие АГ значимо увеличивает шанс выявления СКА только у М. По данным логистического регрессионного анализа, независимо от уровня АД визуализация СКА у М ассоциирована с системным воспалением, провоспалительными интерлейкинами и уровнем ХС ЛПОНП. У Ж нарушение липидного обмена, дисгормональные и метаболические изменения, но не иммунное воспаление, увеличивали вероятность выявления СКА.</p></abstract><trans-abstract xml:lang="en"><p>Objective. To study feasibility of atherosclerotic plaque (AP) detection in individuals working in the Arctic via rotating shifts (ARS) regarding sex, arterial hypertension (HTN), immune inflammation. Design and methods. In Yamburg village (68° 21’ 40” N), 99 males (M) and 81 females (F) with HTN 1,2 stages and normotensive individuals, comparable in age, work experience in ARS, office blood pressure (BP) were examined. Ultrasound examination of carotid arteries, biochemical blood test was performed. Statistica 8,0 (Stat Soft, USA), IBM SPSS Statistics 23 (IBM, USA). Results. Analysis was conducted in M and F groups with AP (n = 98) / without AP (n = 82): among them 57 M (58%), 41 F (51%) were with AP, Рχ2 = 0,6116; with/without HTN. In HTN M, more often than in normotensive M, AP was visualized in carotid arteries lumen: 72% (44 out of 61) vs 34% (13 out of 38), Рχ2 = 0,0209. Probability of AP in M was associated with highly sensitive C-reactive protein (p = 0,052), level of very low density lipoprotein cholesterol (VLDL CH) (p = 0,038), C-peptide (p = 0,004), interleukin IL‑6 (p = 0,048); with level of VLDL CH (p = 0,052) in F only. In M with AP, strong association with mean daily BP parameters was found. Conclusions. Carotid AP associated with HTH in ARS was frequently detected in M. Regardless of PB, AP in M was associated with systemic inflammation, raise of pro-inflammatory cytokines and increase in VLDL CH level. According to logistic regression data in W, lipid metabolism disorders, hormonal changes and metabolic changes, but not immune inflammation, increased the chance of AP imaging in carotid arteries. In HTN M and F, AP was associated with systemic inflammation, pro-inflammatory cytokines due to HTN presence.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>субклинический каротидный атеросклероз</kwd><kwd>иммунное воспаление</kwd><kwd>гендерный фактор</kwd><kwd>арктическая вахта</kwd></kwd-group><kwd-group xml:lang="en"><kwd>subclinical carotid atherosclerosis</kwd><kwd>immune inflammation</kwd><kwd>gender factor</kwd><kwd>Arctic watch</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Vakhtangadze T, Tak RS, Singh U, Baig MS, Bezsonov E. Gender differences in atherosclerotic vascular disease: from lipids to clinical outcomes. Front Cardiovasc Med. 2021;8:707889. doi: 10.3389/fcvm.2021.707889</mixed-citation><mixed-citation xml:lang="en">Vakhtangadze T, Tak RS, Singh U, Baig MS, Bezsonov E. Gender differences in atherosclerotic vascular disease: from lipids to clinical outcomes. Front Cardiovasc Med. 2021;8:707889. doi: 10.3389/fcvm.2021.707889</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fairweather D. Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol. 2015;8(3):49–59. doi: 10. 4137/CMC.S17068</mixed-citation><mixed-citation xml:lang="en">Fairweather D. Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol. 2015;8(3):49–59. doi: 10. 4137/CMC.S17068</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Stone PH. Systemic arterial hypertension: innovative methods to elucidate mechanisms of atherosclerosis and arterial restructuring. J Am Coll Cardiol. 2021;77(5):590–592. doi: 10.1016/j.jacc.2020.12.007</mixed-citation><mixed-citation xml:lang="en">Stone PH. Systemic arterial hypertension: innovative methods to elucidate mechanisms of atherosclerosis and arterial restructuring. J Am Coll Cardiol. 2021;77(5):590–592. doi: 10.1016/j.jacc.2020.12.007</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Usui-Kawanishi F, Takahashi M, Sakai H, Suto W, Kai Y, Chiba Y et al. Implications of immune-inflammatory responses in smooth muscle dysfunction and disease. J Smooth Muscle Res. 2019;55(0):81–107. doi: 10.1540/jsmr.55.81</mixed-citation><mixed-citation xml:lang="en">Usui-Kawanishi F, Takahashi M, Sakai H, Suto W, Kai Y, Chiba Y et al. Implications of immune-inflammatory responses in smooth muscle dysfunction and disease. J Smooth Muscle Res. 2019;55(0):81–107. doi: 10.1540/jsmr.55.81</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Giosia PD, Giorgini P, Stamerra CA, Petrarca M, Ferri C, Sahebkar A. Gender differences in epidemiology, pathophysiology, and treatment of hypertension. Curr Atheroscler Rep. 2018;20(3):13. doi: 10.1007/s11883-018-0716-z</mixed-citation><mixed-citation xml:lang="en">Giosia PD, Giorgini P, Stamerra CA, Petrarca M, Ferri C, SahebkarA. Gender differences in epidemiology, pathophysiology, and treatment of hypertension. Curr Atheroscler Rep. 2018;20(3):13. doi: 10.1007/s11883-018-0716-z</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Кривощеков С. Г., Охотников С. В. Производственные миграции и здоровье человека на Севере. Издательство: СО РАМН (Новосибирск); 2000. 118 с.</mixed-citation><mixed-citation xml:lang="en">Krivoshchekov SG, Okhotnikov SV. Industrial migrations and human health in the North. Publishing house: SB RAMS (Novosibirsk); 2000. 118 p. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Агаджанян Н. А., ГубинД. Г.Десинхроноз: механизмы развития от молекулярно-генетического до организменного уровня. Успехи физиологических наук. 2004;35(2):57–72.</mixed-citation><mixed-citation xml:lang="en">Агаджанян Н. А., ГубинД. Г.Десинхроноз: механизмы развития от молекулярно-генетического до организменного уровня. Успехи физиологических наук. 2004;35(2):57–72.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Скавронская Т. В., Леус А. И., ФедосееваЛ. А. Распространенность артериальной гипертонии среди работников предприятий газовой промышленности в районе Крайнего Севера. Кардиология. 2005;3:84–85.</mixed-citation><mixed-citation xml:lang="en">Скавронская Т. В., Леус А. И., ФедосееваЛ. А. Распространенность артериальной гипертонии среди работников предприятий газовой промышленности в районе Крайнего Севера. Кардиология. 2005;3:84–85.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гапон Л. И., Шуркевич Н. П., Ветошкин А.С., Губин Д. Г. Артериальная гипертония в условиях Крайнего Севера. Десинхроноз и гиперактивность организма как факторы формирования болезни. М.: Мед. книга, 2009. 207 с.</mixed-citation><mixed-citation xml:lang="en">ГапонЛ. И., Шуркевич Н. П., Ветошкин А.С., ГубинД. Г. Артериальная гипертония в условиях Крайнего Севера. Десинхроноз и гиперактивность организма как факторы формирования болезни. М.: Мед. книга, 2009. 207 с.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Шуркевич Н. П., Ветошкин А. С., Гапон Л. И., Симонян А. А. Факторы риска и субклинический каротидный атеросклероз в условиях арктической вахты. Кардиоваскулярная терапия и профилактика. 2019;18(4):86–91. doi: 10.15829/1728- 8800-2019-4-86-91.</mixed-citation><mixed-citation xml:lang="en">Шуркевич Н. П., Ветошкин А. С., Гапон Л. И., Симонян А. А. Факторы риска и субклинический каротидный атеросклероз в условиях арктической вахты. Кардиоваскулярная терапия и профилактика. 2019;18(4):86–91. doi: 10.15829/1728-8800-2019-4-86-91.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi: 10.1093/eurheartj/ehy339</mixed-citation><mixed-citation xml:lang="en">Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi: 10.1093/eurheartj/ehy339</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Barnett HJ, Meldrum HE, Eliasziw M. North American Symptomatic Carotid Endarterectomy Trial (NASCET) collaborators. The appropriate use of carotid endarterectomy. CMAJ. 2002; 166(9):1169–1179.</mixed-citation><mixed-citation xml:lang="en">Barnett HJ, Meldrum HE, Eliasziw M. North American Symptomatic Carotid Endarterectomy Trial (NASCET) collaborators. The appropriate use of carotid endarterectomy. CMAJ. 2002; 166(9):1169–1179.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И. Е., Ощепкова Е. В, Жернакова Ю. В. от имени экспертов. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019;1:6–31. doi: 10.26442/2075082X.2019.1.190179.</mixed-citation><mixed-citation xml:lang="en">Чазова И. Е., Ощепкова Е. В, Жернакова Ю. В. от имени экспертов. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019;1:6–31. doi: 10.26442/2075082X.2019.1.190179.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gaisenok O, Drapkina O. Gender differences in the detection of carotid atherosclerosis: DUPLEX registry crosssectional study results. Monaldi Arch Chest Dis. 2022;7(92):(4). doi: 10.4081/monaldi.2022.2128</mixed-citation><mixed-citation xml:lang="en">Gaisenok O, Drapkina O. Gender differences in the detection of carotid atherosclerosis: DUPLEX registry crosssectional study results. Monaldi Arch Chest Dis. 2022;7(92):(4). doi: 10.4081/monaldi.2022.2128</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sangiorgi G, Roversi S, Zoccai GB, Modena MG, Servadei F, Ippoliti A et al. Sex-related differences in carotid plaque features and inflammation. J Vasc Surg. 2013;57(2):338–344. doi:10.1016/j.jvs.2012.07.052</mixed-citation><mixed-citation xml:lang="en">Sangiorgi G, Roversi S, Zoccai GB, ModenaMG, ServadeiF, Ippoliti A et al. Sex-related differences in carotid plaque features and inflammation. J Vasc Surg. 2013;57(2):338–344. doi:10.1016/j.jvs.2012.07.052</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Santos RL, Silva FB, Ribeiro RF Jr, Stefanon I. Sex hormones in the cardiovascular system. Front Cardiovasc Med. 2022;9:970438. doi: 10.3389/fcvm.2022.970438</mixed-citation><mixed-citation xml:lang="en">Santos RL, Silva FB, Ribeiro RF Jr, Stefanon I. Sex hormones in the cardiovascular system. Front Cardiovasc Med. 2022;9:970438. doi: 10.3389/fcvm.2022.970438</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Onnis C, Dessalvi CC, Cademartiri F, Muscogiuri G, Angius S. Quantitative and qualitative features of carotid and coronary atherosclerotic plaque among men and women. Horm Mol Biol Clin Investig. 2014;18(2):89–103. doi: 10.1515/hmbci2013-0048</mixed-citation><mixed-citation xml:lang="en">Onnis C, Dessalvi CC, Cademartiri F, Muscogiuri G, Angius S. Quantitative and qualitative features of carotid and coronary atherosclerotic plaque among men and women. Horm Mol Biol Clin Investig. 2014;18(2):89–103. doi: 10.1515/hmbci2013-0048</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kunutsor SK, Laukkanen JA. Should inflammatory pathways be targeted for the prevention and treatment of hypertension? Heart. 2019;105(9):665–667. doi: 10.1136/heartjnl-2018-314625</mixed-citation><mixed-citation xml:lang="en">Kunutsor SK, Laukkanen JA. Should inflammatory pathways be targeted for the prevention and treatment of hypertension? Heart. 2019;105(9):665–667. doi: 10.1136/heartjnl-2018-314625</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Trivedi B, Desai R, Mishra K, Hechanova LA, Abolbashari M. Role of sex in atherosclerosis: does sex matter? Curr Cardiol Rep. 2022;24(12):1791–1798. doi: 10.1007/s11886-022-01800-7</mixed-citation><mixed-citation xml:lang="en">Trivedi B, Desai R, Mishra K, Hechanova LA, AbolbashariM. Role of sex in atherosclerosis: does sex matter? Curr Cardiol Rep. 2022;24(12):1791–1798. doi: 10.1007/s11886-022-01800-7</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Pugh D, Dhaun N.Hypertension and vascular inflammation: another piece of the genetic puzzle. Hypertension. 2021;77(1):190– 192. doi: 10.1161/HYPERTENSIONAHA.120.16420</mixed-citation><mixed-citation xml:lang="en">Pugh D, Dhaun N.Hypertension and vascular inflammation: another piece of the genetic puzzle. Hypertension. 2021;77(1):190– 192. doi: 10.1161/HYPERTENSIONAHA.120.16420</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Poznyak AV, Bharadwaj D, Prasad G, Grechko AV, Sazonova MA, Orekhov AN. Anti-inflammatory therapy for atherosclerosis: focusing on cytokines. Int J Mol Sci. 2021;22(13): 7061. doi: 10.3390/ijms22137061</mixed-citation><mixed-citation xml:lang="en">Poznyak AV, Bharadwaj D, Prasad G, Grechko AV, Sazonova MA, Orekhov AN. Anti-inflammatory therapy for atherosclerosis: focusing on cytokines. Int J Mol Sci. 2021;22(13): 7061. doi: 10.3390/ijms22137061</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Vietinghoff S, Koltsova EK. Inflammation in atherosclerosis: a key role for cytokines. Cytokine. 2019;122:154819. doi: 10. 1016/j.cyto.2019.154819</mixed-citation><mixed-citation xml:lang="en">Vietinghoff S, Koltsova EK. Inflammation in atherosclerosis: a key role for cytokines. Cytokine. 2019;122:154819. doi: 10. 1016/j.cyto.2019.154819</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Micha R, Imamura F, Ballmoos MW, Solomon DH, Hernan MA, Ridker PM et al. Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol. 2011; 108(9):1362–1370. doi: 10.1016/j.amjcard.2011.06.054</mixed-citation><mixed-citation xml:lang="en">Micha R, Imamura F, Ballmoos MW, Solomon DH, Hernan MA, Ridker PM et al. Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol. 2011; 108(9):1362–1370. doi: 10.1016/j.amjcard.2011.06.054</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Vitale C, Miceli M, Rosano GM. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric. 2007;10(2):16–20. doi: 10.1097/01.hjh.0000234104.15992.df</mixed-citation><mixed-citation xml:lang="en">Vitale C, Miceli M, Rosano GM. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric. 2007;10(2):16–20. doi: 10.1097/01.hjh.0000234104.15992.df</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kamon T, Kaneko H, Itoh H, Kiriyama H, Mizuno Y, Morita H. Possible gender difference in the association between abdominal obesity, chronic inflammation, and preclinical atherosclerosis in the general population. Int HeartJ. 2021;62(4):837– 842. doi: 10.1536/ihj.20-654</mixed-citation><mixed-citation xml:lang="en">Kamon T, Kaneko H, Itoh H, Kiriyama H, Mizuno Y, Morita H. Possible gender difference in the association between abdominal obesity, chronic inflammation, and preclinical atherosclerosis in the general population. Int HeartJ. 2021;62(4):837– 842. doi: 10.1536/ihj.20-654</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Makita S, Nakamura M, Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke. 2005;36(10):2138–2142. doi: 10.1161/01.STR.0000181740.74005.ee</mixed-citation><mixed-citation xml:lang="en">Makita S, Nakamura M, Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke. 2005;36(10):2138–2142. doi: 10.1161/01.STR.0000181740.74005.ee</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Alves MT, Ortiz MMO, Reis GVOP, Dusse LMSA, Graças Carvalho M, Fernandes AP et al. The dual effect of C-peptide on cellular activation and atherosclerosis: protective or not? Diabetes Metab Res Rev. 2019;35(1):e3071. doi: 10.1002/dmrr.3071</mixed-citation><mixed-citation xml:lang="en">Alves MT, Ortiz MMO, Reis GVOP, Dusse LMSA, Graças Carvalho M, Fernandes AP et al. The dual effect of C-peptide on cellular activation and atherosclerosis: protective or not? Diabetes Metab Res Rev. 2019;35(1):e3071. doi: 10.1002/dmrr.3071</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Z, He J, Ma Q, Xiao M. Association between C-peptide level and subclinical myocardial injury. Front Endocrinol (Lausanne). 2021;12:680501. doi: 10.3389/fendo.2021.680501</mixed-citation><mixed-citation xml:lang="en">Chen Z, He J, Ma Q, Xiao M. Association between C-peptide level and subclinical myocardial injury. Front Endocrinol (Lausanne). 2021;12:680501. doi: 10.3389/fendo.2021.680501</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Collet TH, Ewing SK, Ensrud KE, Laughlin GA, Hoffman AR, Varosy PD et al. Endogenous testosterone levels and the risk of incident cardiovascular events in elderly men: the MrOS prospective study. J Endocr Soc. 2020;4(5): bvaa038. doi: 10.1210/jendso/bvaa038</mixed-citation><mixed-citation xml:lang="en">Collet TH, Ewing SK, Ensrud KE, Laughlin GA, Hoffman AR, Varosy PD et al. Endogenous testosterone levels and the risk of incident cardiovascular events in elderly men: the MrOS prospective study. J Endocr Soc. 2020;4(5): bvaa038. doi: 10.1210/jendso/bvaa038</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Creamer MLR, Wang TW, Babb S, Cullen KA, Day H, Willis G et al. Tobacco product use and cessation indicators among adults — United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(45):1013–1019. doi: 10.15585/mmwr.mm6845a2</mixed-citation><mixed-citation xml:lang="en">Creamer MLR, Wang TW, Babb S, Cullen KA, Day H, Willis G et al. Tobacco product use and cessation indicators among adults — United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(45):1013–1019. doi: 10.15585/mmwr.mm6845a2</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Karlova OO, Kuzminska OV, Baryshnik AI. Changes in the secretary ability of mononuclear cells in patients with atherosclerosis and accompanying pathology, depending on the C-peptide blood plasma. Wiad Lek. 2019;72(4):584–588.</mixed-citation><mixed-citation xml:lang="en">Karlova OO, Kuzminska OV, Baryshnik AI. Changes in the secretary ability of mononuclear cells in patients with atherosclerosis and accompanying pathology, depending on the C-peptide blood plasma. Wiad Lek. 2019;72(4):584–588.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bosevski M, Zlatanovikj N, Petkoska D, Gjorgievski A, Lazarova E, Stojanovska L. Plasma homocysteine in patients with coronary and carotid artery disease: a case control study. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2020;41(1):15–22. doi: 10.2478/prilozi-2020-0019</mixed-citation><mixed-citation xml:lang="en">Bosevski M, Zlatanovikj N, Petkoska D, Gjorgievski A, Lazarova E, Stojanovska L. Plasma homocysteine in patients with coronary and carotid artery disease: a case control study. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2020;41(1):15–22. doi: 10.2478/prilozi-2020-0019</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
